II. Indications
- HIV Infection (combination therapy)
 - Chronic Hepatitis B Infection (Coinfected with HIV)
 
III. Mechanism
- Nucleoside Reverse Transcriptase Inhibitor
 - Emtricitabine is 5-Fluorothiocytidine (FTC), a substituted analog of cytosine (similar to Lamivudine)
 
IV. Precautions
- Risk of severe HBV exacerbation on discontinuation
- Monitor for at least 2 months after discontinuation
 
 
V. Medications
VI. Dosing: HIV Infection
- See HIV Preexposure Prophylaxis
 - Used in combination with other HIV agents (e.g. Tenofovir)
 - Adult (or child weight >33 kg)
- Emtricitabine 200 mg orally daily
 
 - Child (weight <33 kg)
- Age 0 to 3 months: 3 mg/kg orally daily
 - Age >3 months: 6 mg/kg (up to 240 mg) orally daily
 - Weight >33 kg: See Adult dosing
 
 
VII. Dosing: Chronic Hepatitis B Coinfection with HIV (not FDA approved)
- Emtricitabine 200 mg orally daily AND
 - 
                          Tenofovir
                          
- CrCl >=30 ml/min: Tenofovir Alafenamide (Descovy) 25 mg orally daily
 - CrCl >=60 ml/min: Tenofovir Disopoxil (Truvada) 300 mg orally daily
 
 
VIII. Dosing: Renal (Adult)
- 
                          CrCl 30 to 49 ml/min
- Take 200 mg capsule orally every 48 hours (or 120 mg oral solution daily)
 
 - 
                          CrCl 15 to 29 ml/min
- Take 200 mg capsule orally every 72 hours (or 80 mg oral solution daily)
 
 - 
                          CrCl <15 ml/min or Hemodialysis
- Take 200 mg capsule orally every 96 hours (or 60 mg oral solution daily)
 
 
IX. Adverse Effects: Emtricitabine alone
- See nRTI for adverse effects attributed to the class
 - Minimal specific adverse effects and well tolerated
 - Hyperpigmentation of palms and soles
 - Hepatitis B infection flares on withdrawal of medication
 
X. Adverse Effects: Emtricitabine with Tenofovir (Truvada, Descovy)
- See Tenofovir
 - Start-up syndrome (Nausea, Abdominal Pain, Flatulence, Headache) which typically resolves after the first month
 - 
                          Hepatitis B
                          Virus flare
- Associated with abrupt cessation of Antiretroviral therapy
 
 - Acute Renal Failure
 
XI. Safety
XII. Resources
- Emtricitabine (DailyMed)
 - Truvada - Emtricitabine AND Tenofovir Disopoxil (DailyMed)
 - Descovy - Emtricitabine with Tenofovir Alafenamide (DailyMed)
 
Images: Related links to external sites (from Bing)
Related Studies
| emtricitabine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB | Generic | $0.56 each | 
| truvada (on 7/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| TRUVADA 200 MG-300 MG TABLET | Generic | $0.56 each | 
| descovy (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| DESCOVY 200-25 MG TABLET | $66.13 each | |